12-64430230-A-G
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_007235.6(XPOT):āc.1919A>Gā(p.Asp640Gly) variant causes a missense change. The variant allele was found at a frequency of 0.0000322 in 1,612,624 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.00023 ( 0 hom., cov: 32)
Exomes š: 0.000012 ( 0 hom. )
Consequence
XPOT
NM_007235.6 missense
NM_007235.6 missense
Scores
1
10
8
Clinical Significance
Conservation
PhyloP100: 6.92
Genes affected
XPOT (HGNC:12826): (exportin for tRNA) This gene encodes a protein belonging to the RAN-GTPase exportin family that mediates export of tRNA from the nucleus to the cytoplasm. Translocation of tRNA to the cytoplasm occurs once exportin has bound both tRNA and GTP-bound RAN. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 0 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.094283104).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
XPOT | NM_007235.6 | c.1919A>G | p.Asp640Gly | missense_variant | 17/25 | ENST00000332707.10 | NP_009166.2 | |
XPOT | XM_017018748.2 | c.1919A>G | p.Asp640Gly | missense_variant | 17/25 | XP_016874237.1 | ||
XPOT | XM_047428193.1 | c.1919A>G | p.Asp640Gly | missense_variant | 17/25 | XP_047284149.1 | ||
XPOT | XM_047428195.1 | c.485A>G | p.Asp162Gly | missense_variant | 6/14 | XP_047284151.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
XPOT | ENST00000332707.10 | c.1919A>G | p.Asp640Gly | missense_variant | 17/25 | 2 | NM_007235.6 | ENSP00000327821 | P1 | |
XPOT | ENST00000542958.5 | n.957A>G | non_coding_transcript_exon_variant | 6/8 | 5 | |||||
XPOT | ENST00000538086.5 | c.*396A>G | 3_prime_UTR_variant, NMD_transcript_variant | 6/7 | 5 | ENSP00000444345 | ||||
XPOT | ENST00000541842.1 | downstream_gene_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.000230 AC: 35AN: 152218Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
35
AN:
152218
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000561 AC: 14AN: 249392Hom.: 0 AF XY: 0.0000519 AC XY: 7AN XY: 134816
GnomAD3 exomes
AF:
AC:
14
AN:
249392
Hom.:
AF XY:
AC XY:
7
AN XY:
134816
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000116 AC: 17AN: 1460288Hom.: 0 Cov.: 30 AF XY: 0.00000826 AC XY: 6AN XY: 726454
GnomAD4 exome
AF:
AC:
17
AN:
1460288
Hom.:
Cov.:
30
AF XY:
AC XY:
6
AN XY:
726454
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000230 AC: 35AN: 152336Hom.: 0 Cov.: 32 AF XY: 0.000242 AC XY: 18AN XY: 74500
GnomAD4 genome
AF:
AC:
35
AN:
152336
Hom.:
Cov.:
32
AF XY:
AC XY:
18
AN XY:
74500
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
3
ESP6500EA
AF:
AC:
0
ExAC
AF:
AC:
7
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 13, 2024 | The c.1919A>G (p.D640G) alteration is located in exon 17 (coding exon 16) of the XPOT gene. This alteration results from a A to G substitution at nucleotide position 1919, causing the aspartic acid (D) at amino acid position 640 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Uncertain
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D
M_CAP
Benign
D
MetaRNN
Benign
T
MetaSVM
Benign
T
MutationAssessor
Uncertain
M
MutationTaster
Benign
D
PrimateAI
Benign
T
PROVEAN
Uncertain
D
REVEL
Uncertain
Sift
Uncertain
D
Sift4G
Uncertain
D
Polyphen
P
Vest4
MVP
MPC
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at